Search

everythinglearnresearchcommunity

for

Search:↓

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

Betamethasone is more effective long-term for alopecia areata than hydroxychloroquine.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

The laser therapy device effectively increased hair growth in people with androgenetic alopecia.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Baricitinib was effective in treating alopecia areata in two major trials.

SIM01 significantly reduced post-COVID symptoms and is safe.

Standardized treatment protocols are needed for children with androgenetic alopecia.

The treatment slightly increased hair growth and was safe for most women.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Alefacept does not effectively treat severe alopecia areata.